Abstract
Introduction: We evaluated the immunoglobulin (Ig) G antibody response against the nucleocapsid protein (NP) and the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 in a cohort of 86 individuals in Venezuela, before and after receiving the Sputnik V vaccine.
Methods: Antibody responses against NP and RBD were determined with an enzyme-linked immunosorbent assay just before, 3 weeks after the first, and 6 weeks after the second dose of the vaccine.
Results: Before vaccination, 59 individuals were seronegative, and 27 seropositive for NP and/or RBD. Of the seronegative cohort, 42% did not develop an IgG immune response against RBD after the first vaccine dose, but 100% had a strong IgG response after 2 doses. All seropositive individuals developed a strong IgG antibody response against RBD after the first vaccine dose, with antibody levels ∼40% higher than seronegative individuals who had received 2 doses. Previously seropositive subjects showed no significant increase in IgG antibody response against RBD after the second vaccine dose.
Conclusions: We demonstrate that 2 doses of the Sputnik V vaccine triggered antibody response in all study individuals. The second Sputnik V dose had no impact on IgG response for those seropositive for SARS-CoV-2 antigens before vaccination.
Keywords: IgG antibodies; S/P ratio; Sputnik V vaccine; nucleocapsid protein (NP); receptor-binding domain (RBD); vaccine booster dose.
【저자키워드】 IgG antibodies, Receptor-binding domain (RBD), S/P ratio, Sputnik V vaccine, nucleocapsid protein (NP), vaccine booster dose., 【초록키워드】 SARS-CoV-2, IgG, Vaccine, vaccination, antibody, Antibody Response, Spike protein, nucleocapsid protein, vaccine dose, enzyme-linked immunosorbent assay, Cohort, Antibody responses, IgG antibody, Receptor-binding domain, Immunoglobulin, IgG antibodies, RBD, antibody levels, SARS-CoV-2 antigen, booster dose, seropositive, seronegative, SARS-CoV-2 antigens, dose, Venezuela, IgG response, second dose, enzyme, significant increase, individual, domain, doses, seropositive subjects, IgG immune response, enzyme-linked immunosorbent, develop, evaluated, receiving, the spike protein, the receptor-binding domain, triggered, individuals, had no, the vaccine, antibody response against, S/P, seropositive individual, seropositive subject, 【제목키워드】 SARS-CoV-2, vaccine dose, Immunoglobulin G, seropositive individual,